* If you are interested in this trial please be sure to fill out the form at the bottom of this page
Alzheimer’s Disease is a progressive brain disease that slowly destroys brain cells. Alzheimer’s is the most common form of dementia and accounts for60-80% of all dementia cases. Symptoms can vary widely between individuals but include memory loss, difficulty performing daily activities, and changes injudgment, reasoning, behaviour, and emotions. Symptoms usually develop slowly and get worse over time. Although it can be easy to assume memory loss is part of the aging process, Alzheimer’s disease is not a normal part of aging.
Alzheimer’s disease affects not only the individual who is diagnosed but also family members, friends, and caregivers. There is currently no cure forAlzheimer’s disease but there are several medications available that can help with symptoms. However, these medications can affect people differently and not everyone will respond the same way to medications.
Bluewater Clinical Research Group is proud to help contribute to this research and we are actively looking for volunteers diagnosed with mild-to-moderateAlzheimer’s disease to participate in a new clinical trial to help find new potential treatment options.
To find out more, or see if you or your loved one may qualify, please provide us with your contact information below and one of our enrolment facilitators will be happy to get in touch with you.
To see if you qualify, please provide us with your contact information below. As everyone has different schedules, we may even text you to set up a time to connect. Thank you.
We would love to hear from you! Want to learn more about clinical studies in general or wish to explore whether you would qualify for a specific clinical trial? Connect with us today!
COPD is a progressive lung disease characterized by persistent airflow limitation or obstruction and an inflammatory response of the airways and lungs